Do you prescribe Tarceva to your cancer patients?
May 15, 2009 – 9:54 amThe FDA has added a new warning label to the popular Genentech and OSI Pharmaceuticals cancer drug following reports of skin reactions, eye problems, gastrointestinal perforations and some fatalities. To read Genentech and OSI’s letter to healthcare professionals, click here:
http://www.fda.gov/medwatch/safety/2009/Tarceva_DHCP_Letter_April09.pdf
